Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kontrol Technologies Corp N.KNR

Alternate Symbol(s):  KNRLF

Kontrol Technologies Corp. is a provider of energy management, continuous air quality and emission solutions to commercial and industrial consumers. It delivers building intelligence through the Internet of things (IoT), software and cloud technology as well as project integration. Its smart technology is deployed to customers through a cloud-based interface accessible on desktops and mobile devices. It collects real-time and historical data using IoT sensors and direct connection to industrial control systems, bringing various sources of asset performance data into the cloud where smart-learning software is applied to optimize performance. The Company, through CEM Specialties Inc., offers turn-key emission monitoring equipment, integration design, manufacturing, service, repairs, and on-site performance certification testing. It offers building heating, ventilation, and air conditioning integration, automation and retrofits to enhance the energy efficiency of buildings and facilities.


NEO:KNR - Post by User

Comment by Qrewpton Nov 17, 2020 7:40pm
303 Views
Post# 31919462

RE:Help!!

RE:Help!!They have an existing business that does $14+ ltm Revenue.  So that's worth at least 30 to 60m.  That means BioCloud is being valued about $30 to $60m given the current market cap.

They need one large order to get the ball rolling, let's say this can bring the cost of a unit down to $8k CAD.  So if they can sell 3750 units at this price Biocloud is selling for 1x to 2x Revenues. 

Let's say net profit margin on BioCloud is 15%, ,meaning these 3750 units will net them $4.5m to $9m of cashflow - so P/E for BioCloud is 6.6, if they can only ever sell 24k units over the life of the product, and the IP is worth zero, you get your market cap back in cash.

I think it's very unlikely that they only ever sell 24k units.  If they make one large sale to get this ball rolling, this stock is worth $10 to $15 very conservatively.  If they don't make a sale and bioCloud is worth zero, this stock is worth $1 to $2.  

The asymetry of the risk/reward on this stock is nuts, it's completely mispriced. 

The vaccine news has obviously tempered expectations for KNR, but c'mon, those expectations were exceedingly low, you aren't paying up for expectations in this name.  Let's think about what the vaccines really mean to KNR.

Reallity is that the vaccines are a fall 2020 event, Moderna and Pfizer together will have produced what, 500-600m doses by 2021?  At 2 Doses per treatment, I don't think that even covers the USA if all goes as planned.  There are more vaccines in the pipelines but governments know that they can't just wait with their heads in the sand until such a time when we can get that herd immunity.  Even then, are these vaccines really 95% effective in seniors...probably not.  Vaccines are targetting the spike protein, hoping that they virus doesn't mutate, but it likely will, there is a good chance we will need Gen2 or Gen3 vaccines to put CoV2 to bed.  The virus will probably still be present in our environments for several more years, there will likely be segments of the population which will still be vulnerable to the disease until it gets eliminated completely.  

Now this IS an investment and my thesis might end up being wrong, if KNR was a poker hand, it would be a full house, with a giant stack of chips piled in the kitty.  It's likely going to work out, but I've lost to 4 of a kind before, doesn't mean that placing the bet was the wrong decision.


Yobigs wrote:
I notice the majority of you are optimistic for the next two weeks
personally I do not see that knr will go up and cannot exceed 3.5  $ at the moment
am I wrong?


<< Previous
Bullboard Posts
Next >>